NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA, THE
UNITED KINGDOM OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE
DISTRIBUTION, PUBLICATION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES
NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.

Oslo, 22 May 2026: Reference is made to the stock exchange announcements
published by NEXT Biometrics Group ASA (OSE: NEXT) ("NEXT" or the "Company") on
18 March 2026 regarding the 82% underwritten rights issue of new shares with
preferential subscription rights for the Company's existing shareholders to
raise gross proceeds of up to NOK 50 million (the "Rights Issue"), and the stock
exchange announcement published on 19 May 2026 where the Company announced that
the annual general meeting had approved the Rights Issue.

The Financial Supervisory Authority of Norway (Nw.: Finanstilsynet) has today,
on 22 May 2026, approved the Company's prospectus prepared in connection with
the Rights Issue (the "Prospectus").
Arctic Securities AS is acting as manager (the "Manager") in the Rights Issue.

Subject to applicable local securities laws, the Prospectus and the subscription
form for the Rights Issue, will be made available on the website of the Manager:
https://arctic.com/offerings

The subscription period for the Rights Issue will take place from 09:00 hours
(CEST) on 26 May 2026 to 9 June 2026 at 16:30 hours (CEST).

For further information, please contact:
Ulf Ritsvall, CEO
Email: ulf.ritsvall@nextbiometrics.com
Eirik Underthun, CFO
Email: eirik.underthun@nextbiometrics.com  

(1) Arctic Securities AS has entered into put option agreements for a
predetermined consideration equal to the underwriting fee with a number of
natural and legal persons according to which Arctic Securities AS has the right
to sell any shares acquired in the Rights Issue at a price corresponding to the
Subscription Price in the Rights Issue.

# # # # # 

About NEXT Biometrics 

NEXT Biometrics is a pioneer of high-security biometric authentication, enabling
users to live simpler, safer lives.  

NEXT Biometrics was founded on the belief that strong authentication and
identification can be secure, seamless and cost effective for governments and
businesses with Active Thermal® technology. More than 25 years later, NEXT
has retained its Norwegian heritage and grown to serve customers globally.  

Today, our solutions are used by billions of users each year across 10+ national
ID and local programs, 150.000+ POS terminals, 25+ laptop and tablet models from
tier-1 OEMs, and physical and logical access control implementations.
Through state-of-the-art technology, deep industry expertise and close
collaboration with partners for seamless integration, Active Thermal® biometrics
can make life simpler and safer for everyone.  

For more information, visit NEXT Biometrics, read our blog and follow us
on LinkedIn. NEXT Biometrics is listed on Euronext (NEXT.OL).  

Important notice:

This announcement is not and does not form a part of any offer to sell, or a
solicitation of an offer to purchase, any securities of the Company. Copies of
this announcement are not being made and may not be distributed or sent into any
jurisdiction in which such distribution would be unlawful or would require
registration or other measures.
The securities referred to in this announcement have not been and will not be
registered under the U.S. Securities Act of 1933, as amended (the "Securities
Act"), and accordingly may not be offered or sold in the United States absent
registration or an applicable exemption from the registration requirements of
the Securities Act and in accordance with applicable U.S. state securities laws.
The Company does not intend to register any part of the offering in the United
States or to conduct a public offering of securities in the United States. Any
sale in the United States of the securities mentioned in this announcement will
be made solely to "qualified institutional buyers" as defined in Rule 144A under
the Securities Act.

In any EEA Member State, this communication is only addressed to and is only
directed at qualified investors in that Member State within the meaning of the
Prospectus Regulation, i.e., only to investors who can receive the offer without
an approved prospectus in such EEA Member State. The expression "Prospectus
Regulation" means Regulation (EU) 2017/1129 as amended (together with any
applicable implementing measures in any Member State.
This communication is only being distributed to and is only directed at persons
in the United Kingdom that fall within the definition of "investment
professionals" in Article 19(5) of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005, as amended (the "Order") or (ii) high net
worth entities falling within Article 49(2)(a) to (d) of the Order; or (iii) are
other persons to whom it may otherwise lawfully be communicated (all such
persons together being referred to as "Relevant Persons"). Any person who is not
a Relevant Person must not act or rely on this Investor Presentation or any of
its contents. Any investment or investment activity to which this communication
relates is available only for Relevant Persons and will be engaged in only with
Relevant Persons. Persons distributing this communication must satisfy
themselves that it is lawful to do so.

Matters discussed in this announcement may constitute forward-looking
statements. Forward-looking statements are statements that are not historical
facts and may be identified by words such as "believe", "expect", "anticipate",
"strategy", "intends", "estimate", "will", "may", "continue", "should" and
similar expressions. The forward-looking statements in this release are based
upon various assumptions, many of which are based, in turn, upon further
assumptions. Although the Company believes that these assumptions were
reasonable when made, these assumptions are inherently subject to significant
known and unknown risks, uncertainties, contingencies and other important
factors which are difficult or impossible to predict, and are beyond their
control. Such risks, uncertainties, contingencies and other important factors
could cause actual events to differ materially from the expectations expressed
or implied in this release by such forward-looking statements. The Company does
not make any guarantee that the assumptions underlying the forward-looking
statements in this announcement are free from errors nor does it accept any
responsibility for the future accuracy of the opinions expressed in this
announcement or any obligation to update or revise the statements in this
announcement to reflect subsequent events. You should not place undue reliance
on the forward-looking statements in this announcement.

The information, opinions and forward-looking statements contained in this
announcement speak only as at its date, and are subject to change without
notice. The Company does not undertake any obligation to review, update,
confirm, or to release publicly any revisions to any forward-looking statements
to reflect events that occur or circumstances that arise in relation to the
content of this announcement.

This announcement is for information purposes only and is not to be relied upon
in substitution for the exercise of independent judgment. It is not intended as
investment advice and under no circumstances is it to be used or considered as
an offer to sell, or a solicitation of an offer to buy any securities or a
recommendation to buy or sell any securities of the Company. 

The distribution of this announcement and other information may be restricted by
law in certain jurisdictions. Persons into whose possession this announcement or
such other information should come are required to inform themselves about and
to observe any such restrictions.
y\
law in certain jurisdictions. Persons into whose possession this announcement or\
such other information should come are required to inform themselves about and\
to observe any such restrictions.\